Liver iron overload induced by tamoxifen in diabetic and non-diabetic female Wistar rats

BioMetals

Volumn 21, Issue 2, 2008, Pages 171-178

  Jatobá, Carlos André Nunes ^a   De Rezende, Adriana Augusto ^a   De Paiva Rodrigues, Sarah Jane ^a   De Almeida Câmara, Maria Margareth ^a   Das Graças Almeida, Maria ^a   Freire Neto, Francisco ^a   Da Rocha, Luiz Reginaldo Menezes ^a   Da Medeiros, Aldo Cunha ^a   Brandão Neto, José ^a   De Carvalho Formiga, Maria Célia ^a   De Azevedo, Ítalo Medeiros ^a   De Oliveira Ramos, Ana Maria ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Diabetes mellitus; Hemosiderin; Iron metabolism; Liver; Siderosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; EOSIN; GLUCOSE; HEMATOXYLIN; LIVER ENZYME; SORBITOL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOCHEMISTRY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; IRON METABOLISM; IRON OVERLOAD; LIVER; LIVER FUNCTION; LIVER HEMOSIDEROSIS; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; BREAST NEOPLASMS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HUMANS; IRON; LIVER; RANDOM ALLOCATION; RATS; RATS, WISTAR; TAMOXIFEN;

RATTUS; RATTUS NORVEGICUS;

EID: 41049083538     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-007-9105-8     Document Type: Article

References (43)

1. Anderson GJ, Frazer DM (2005) Hepatic iron metabolism. Semin Liver Dis 25(4):420-432
2. Atanasiu V, Manolescu B, Stoian I (2007) Hepcidin-central regulator of iron matabolism. Eur J Haematol 78(1):1-10
3. Bacon BR, Britton RS (1990) The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 11:127-173
4. Bacon BR, Park CH, Brittenham R, O'Neil R, Tavil AS (1985) Hepatic mitocondrial metabolism in rats with chronic dietary iron overload. Hepatology 5:789-797
5. Bergmeyer HU, Scheibe P, Wahlefeld AW (1978) Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem 24:58-73
6. Bonnani V, Veronesi U (1999) The Italian tamoxifen prevention trial. Dis Markers 15:199-200
7. Britton RS, Ramm GA, Olynik J et al (1994) Pathophysiology of iron toxicity. Adv Exp Med Biol 356:239-253
8. Brunt EM (2005) Pathology of hepatic iron overload. Semin Liver Dis 25(4):392-401
9. Brunzell JD (1978) Use of fructose, sorbitol, or xylitol as a sweetener in diabetes mellitus. J Am Diet Assoc 73:499-506
10. Bulaj ZJ, Phillips JD, Ajioka RS et al (2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95:1565-1571
11. Cole MP, Jones CTA, Todd IDH (1971) A new anti-estrogenic agent in late breast cancer: an early clinical appraisal of ICI46474. Br J Cancer 25:270-275
12. Duarte VMG, Ramos AMO, Rezende LA et al (2005) Osteopenia: a bone disorder associated with diabetes mellitus. J Bone Miner Metab 23:58-68
13. Elefsiniotis IS, Pantazis KD, Pallis L et al (2004) Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. Eur J Gastroenterol Hepatol 16:593-598
14. Fleming RE (2005) Advances in understanding the molecular basis for the regulation of dietary iron absorption. Curr Opin Gastroenterol 21(12):201-206
15. Ganz T (2005) Hepcidin: a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18:171-182
16. Gualdi R, Casalgrandi G, Montosi G et al (1994) Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology 107:1118-1124
17. Kim SY, Laxmi YR, Suzuki N, Ogura K, Watabe T, Duffel MW, Shibutani S (2005) Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers. Drug Metab Dispos 33(11):1673-1678
18. Kim SY, Suzuki N, Laxmi YR, Shibutani S (2006) Inefficient repair of tamoxifen-DNA adducts in rats and mice. Drug Metab Dispos 34(2):311-317
19. Kurt M, Altundag K, Altundag O, Turen S (2005) Tamoxifen may icrease insulin requirement in breast cancer patients with type 1 diabetes through its agonistic activity on splenic endothelial cells and inhibitory effect on pancreatic plasma cells. Med Hypotheses 65(4):815-816
20. Lee YS, Kang YS, Lee SH, Kim JA (2000) Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ 7(10):925-932
21. Leonarduzzi G, Scavazza A, Biasi F et al (1997) The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta 1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11:851-857
22. Lox C, Ronaghan C, Cobos E (1998) Blood chemistry profiles in menopausal women administered for breast cancer. Gen Pharmacol 1:121-124
23. Maher JJ, Zia S, Tzangarakis C (1994) Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts. Alcohol Clin Exp Res 18:103-409
24. Malina L, Mottl V, Michalíková H (2005) Is tamoxifene porphyrinogenic? Cas Lek Cesk 144:262-264
25. Maruyama S, Hirayama C, Abe J, Tanaka J, Matsui K. (1995) Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy. Dig Dis Sci 40:2602-2607
26. Masson P (1929) Some histological methods. Trichrome staining and their preliminary technique. J Techn Meth 12:75-90
27. Milionis HJ, Liberopoulos EN, Elisaf MS (2001) Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus. Diab Metab 27:160-163
28. Morgan LR Jr, Schein OS, Wooley PV et al (1976) Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. Cancer Treat Rep 60:1437-1443
29. National Research Council Guide for the Care and Use of Laboratory Animals (1996) National Academy Press, Washington
30. Niemi M, Korhonen LK (1972) Histochemical methods in diagnostic pathology. Int Pathol 13:11-28
31. Olynyk JK, O'Neill R, Britton S, Bacon BR (1994) Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic inplications. Gastroenterology 106:674-677
32. Ortega L, Ladero JM, Carreras MP et al (2005) A computer-assisted quantitative analysis of iron overload in liver biopsies. A comparison with histological and bioquemical methods. Pathol Res Pract 201:673-677
33. Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, Williams DP (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45:177-202
34. Parvez S, Tabassum H, Rehman H et al (2006) Catechin prevents tamoxifen-induced oxidative stress and bioquemical perturbations in mice. Toxicology 225:109-118
35. Pinto HC, Batista A, Camilo ME, de Costa EB, Valente A, de Moura MC (1995) Tamoxifen-associated steatohepatitis report of three cases. J Hepatol 23:95-97
36. Reeves PG, Nielson FH, Fahey Junior GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of AIN-76th Rodent Diet. J Nutr 123:1939-1951
37. Sampietro M, Fiorelli G, Fargion S (1999) Iron overload in porphyria cutanea tarda. Haematologica 84:248-253
38. Sargent LM, Dragan YP, Bahnub N, Wiley JE, Sattler CA, Schoeder P, Sattler GL, Jordan VC, Pitot HC (1994) Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Res 54(13):3357-3360
39. Silva P, Mota TC, Almeida SB, Câmara MM (2005) Effect of tamoxifen on plasma proteins in diabetes mellitus type 1. Acta Cir Bras 20:86-93
40. Stevens A, Chalk BT (2001) Pigments and minerals. In: Bancroft JD, Stevens A (eds) Theory and practice of histological techniques. Churchill Livingstone, London, pp 243-267
41. Tibi L, Collier A, Patrick AW, Clarke BF, Smith AF (1988) Plasma alkaline phosphatase isoenzymes in diabetes mellitus. Clin Chim Acta 177:147-155
42. Trinder D, Morgan E (1998) Mechanisms of ferric citrate uptake by human hepatoma cells. Am J Physiol 275:G279-G286
43. Tsuji Y (2005) Jun D activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 24(51):7567-7578